JP2014518063A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518063A5
JP2014518063A5 JP2014513625A JP2014513625A JP2014518063A5 JP 2014518063 A5 JP2014518063 A5 JP 2014518063A5 JP 2014513625 A JP2014513625 A JP 2014513625A JP 2014513625 A JP2014513625 A JP 2014513625A JP 2014518063 A5 JP2014518063 A5 JP 2014518063A5
Authority
JP
Japan
Prior art keywords
crosslinker
peptide
modified
igf
lysosomal enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014513625A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014518063A (ja
JP6300720B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/039705 external-priority patent/WO2012166653A2/en
Publication of JP2014518063A publication Critical patent/JP2014518063A/ja
Publication of JP2014518063A5 publication Critical patent/JP2014518063A5/ja
Application granted granted Critical
Publication of JP6300720B2 publication Critical patent/JP6300720B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014513625A 2011-05-27 2012-05-25 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法 Active JP6300720B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161490957P 2011-05-27 2011-05-27
US61/490,957 2011-05-27
PCT/US2012/039705 WO2012166653A2 (en) 2011-05-27 2012-05-25 Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017133655A Division JP2017225444A (ja) 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Publications (3)

Publication Number Publication Date
JP2014518063A JP2014518063A (ja) 2014-07-28
JP2014518063A5 true JP2014518063A5 (cg-RX-API-DMAC10.html) 2018-02-15
JP6300720B2 JP6300720B2 (ja) 2018-03-28

Family

ID=47260229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014513625A Active JP6300720B2 (ja) 2011-05-27 2012-05-25 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法
JP2017133655A Pending JP2017225444A (ja) 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017133655A Pending JP2017225444A (ja) 2011-05-27 2017-07-07 リソソーム蓄積症の改善された治療のための組換えリソソーム酵素にターゲティングペプチドをカップリングするための方法

Country Status (21)

Country Link
US (2) US9545450B2 (cg-RX-API-DMAC10.html)
EP (1) EP2714752B1 (cg-RX-API-DMAC10.html)
JP (2) JP6300720B2 (cg-RX-API-DMAC10.html)
KR (2) KR20190022943A (cg-RX-API-DMAC10.html)
CN (2) CN108586621A (cg-RX-API-DMAC10.html)
BR (1) BR112013030432A2 (cg-RX-API-DMAC10.html)
CA (1) CA2836318C (cg-RX-API-DMAC10.html)
CY (1) CY1120485T1 (cg-RX-API-DMAC10.html)
DK (1) DK2714752T3 (cg-RX-API-DMAC10.html)
ES (1) ES2660185T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20180291T1 (cg-RX-API-DMAC10.html)
HU (1) HUE038172T2 (cg-RX-API-DMAC10.html)
LT (1) LT2714752T (cg-RX-API-DMAC10.html)
NO (1) NO2820016T3 (cg-RX-API-DMAC10.html)
PL (1) PL2714752T3 (cg-RX-API-DMAC10.html)
PT (1) PT2714752T (cg-RX-API-DMAC10.html)
RS (1) RS56913B1 (cg-RX-API-DMAC10.html)
SI (1) SI2714752T1 (cg-RX-API-DMAC10.html)
SM (1) SMT201800101T1 (cg-RX-API-DMAC10.html)
TR (1) TR201802230T4 (cg-RX-API-DMAC10.html)
WO (1) WO2012166653A2 (cg-RX-API-DMAC10.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9925303B2 (en) * 2012-11-13 2018-03-27 Edwards Lifesciences Corporation Methods for cross-linking bioprosthetic tissue using bio-orthogonal binding pairs
EP2976092B1 (en) 2013-03-15 2020-04-22 Amicus Therapeutics, Inc. Chemical crosslinkers
CN111233992B (zh) * 2014-04-04 2024-07-19 韦斯塔隆公司 人工活化的肽
WO2016025519A1 (en) * 2014-08-11 2016-02-18 Shire Human Genetic Therapies, Inc. Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
JP6851964B2 (ja) * 2014-09-30 2021-03-31 アミカス セラピューティックス インコーポレイテッド 炭水化物が増大している非常に強力な酸性アルファ−グルコシダーゼ
CN104356238B (zh) * 2014-10-15 2018-01-09 大连理工大学 一种重组蛋白a亲和配基的定点固定化方法
EP3268589B1 (en) * 2015-03-11 2019-06-26 OCV Intellectual Capital, LLC Methods for filling mufflers with fibrous material
HK1253529A1 (zh) 2015-11-06 2019-06-21 Biomarin Pharmaceutical Inc. 用於检测中和溶酶体酶的摄取的抗体或其它因子的基於细胞的测定
MY207684A (en) * 2015-12-08 2025-03-12 Regeneron Pharma Compositions and methods for internalizing enzymes
AU2018281280B2 (en) 2017-06-07 2024-12-19 Regeneron Pharmaceuticals, Inc. Compositions and methods for internalizing enzymes
JP7356911B2 (ja) 2017-06-14 2023-10-05 ヴァイロメティックス アーゲー 呼吸器合胞体ウイルスに対する予防のための環状ペプチド
BR112020005271A2 (pt) 2017-10-02 2020-09-15 Denali Therapeutics Inc. proteína, polipeptídeo, polinucleotídeo, vetor, célula hospedeira, método para produção de um polipeptídeo, métodos de tratamento de um distúrbio, de diminuição do acúmulo, de monitoramento, de transporte de um agente e de tratamento de um lsd e composição farmacêutica
CN112040985A (zh) 2018-02-07 2020-12-04 瑞泽恩制药公司 用于递送治疗性蛋白质的方法和组合物
US11492610B2 (en) 2018-03-08 2022-11-08 California Institute Of Technology Sample multiplexing for single-cell RNA sequencing
TW202344691A (zh) 2018-04-30 2023-11-16 美商阿米庫斯醫療股份有限公司 基因治療構築體及使用方法
EP3793591A1 (en) 2018-05-17 2021-03-24 Regeneron Pharmaceuticals, Inc. Anti-cd63 antibodies, conjugates, and uses thereof
JP7577650B2 (ja) 2018-10-10 2024-11-05 アミカス セラピューティックス インコーポレイテッド ジスルフィド結合により安定したポリペプチド組成物及びその使用方法
WO2020113036A2 (en) * 2018-11-28 2020-06-04 Promega Corporation Reactive peptide labeling
EP3897747A4 (en) 2018-12-19 2022-12-07 The Board of Trustees of the Leland Stanford Junior University BIFUNCTIONAL MOLECULES FOR LYSOSOMA TARGETING AND RELATED COMPOSITIONS AND METHODS
CA3121724A1 (en) 2018-12-20 2020-06-25 Virometix Ag Lipopeptide building blocks and synthetic virus-like particles
US20220193261A1 (en) * 2019-04-30 2022-06-23 The Trustees Of The University Of Pennsylvania Compositions useful for treatment of pompe disease
CN110373405B (zh) * 2019-07-24 2023-12-15 杭州恩和生物科技有限公司 一种接枝聚合物的生物酶及其制备方法和固定方法
JP2022552254A (ja) * 2019-10-10 2022-12-15 アミカス セラピューティックス インコーポレイテッド バリアントigf2構築体
US20230355737A1 (en) 2020-09-28 2023-11-09 Dbv Technologies Particle comprising an rsv-f protein for use in rsv vaccination
AR124216A1 (es) 2020-12-01 2023-03-01 Univ Pennsylvania Composiciones nuevas con motivos selectivos específicos del tejido y composiciones que las contienen
AU2022262771A1 (en) 2021-04-23 2023-11-02 The Trustees Of The University Of Pennsylvania Novel compositions with brain-specific targeting motifs and compositions containing same
EP4359430A4 (en) 2021-06-23 2025-07-16 Lycia Therapeutics Inc BIFUNCTIONAL COMPOUNDS CONTAINING IGF-2 POLYPEPTIDES
JP2024524614A (ja) 2021-07-14 2024-07-05 ライシア セラピューティクス, インコーポレイテッド Asgpr細胞表面受容体結合化合物及びコンジュゲート
EP4634394A2 (en) 2022-12-17 2025-10-22 The Trustees of The University of Pennsylvania Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same
WO2024130070A2 (en) 2022-12-17 2024-06-20 The Trustees Of The University Of Pennsylvania Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof
WO2025007046A1 (en) 2023-06-29 2025-01-02 The Trustees Of The University Of Pennsylvania Mutant aav with central nervous system targeting motifs and compositions containing same
CN121693342A (zh) 2023-07-12 2026-03-17 维罗迈科斯股份公司 肺炎球菌抗原的组合物
KR20260114566A (ko) 2023-11-14 2026-07-22 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 심근 및 골격근-특이적 표적화 모티프를 갖는 조성물 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1118334A1 (en) * 2000-01-11 2001-07-25 Aventis Behring Gesellschaft mit beschränkter Haftung Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases
US7560424B2 (en) * 2001-04-30 2009-07-14 Zystor Therapeutics, Inc. Targeted therapeutic proteins
US20030072761A1 (en) * 2001-10-16 2003-04-17 Lebowitz Jonathan Methods and compositions for targeting proteins across the blood brain barrier
US7355018B2 (en) 2003-09-30 2008-04-08 Regeneron Pharmaceuticals, Inc. Modified IGF1 polypeptides with increased stability and potency
WO2009137721A2 (en) 2008-05-07 2009-11-12 Zystor Therapeutics, Inc. Lysosomal targeting peptides and uses thereof
PL3912643T3 (pl) * 2009-02-13 2023-01-23 Immunomedics Inc. Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo

Similar Documents

Publication Publication Date Title
JP2017225444A5 (cg-RX-API-DMAC10.html)
CA2836318C (en) Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
CA2052375C (en) Parathyroid hormone derivatives
CN101133082B (zh) 酰化的glp-1化合物
WO2013065009A1 (en) A sortase-click reaction suite for synthesis of multivalent dendrimeric protein assembly
JP2015534568A (ja) Irf5に結合する細胞透過性ペプチド
MX2011000847A (es) Proteinas conjugadas con eficacia prolongada in vivo.
KR20100014215A (ko) 신규 단백질 접합체 및 그것의 제조 방법
CN117304281B (zh) 一种重组rsv f蛋白及其应用
AU2012300934A1 (en) Cyclosporin derivatives
JP2014506450A5 (cg-RX-API-DMAC10.html)
CN109384839B (zh) 胰高血糖素样肽-1类似物及其用途
TW577897B (en) Conjugates useful in the treatment of prostate cancer
CN108341880A (zh) 含有胰高血糖素样肽-1和胰高血糖素的片段类似物的嵌合多肽及其用途
JPH02500517A (ja) ペプチド化合物
WO2014082080A2 (en) Methods for coupling targeting peptides onto recombinant lysosomal enzymes for improved treatments of lysosomal storage diseases
JPS6084298A (ja) 新規生理活性ポリペプチドおよびその製造法
JP2015522532A (ja) TNF−α阻害剤としてのTACEプロドメインの変異体およびその医学的使用
CN108341879A (zh) 一种嵌合多肽及其用途
ES2537701T3 (es) Un método de hidrólisis de péptidos, uso de una composición como agente bacteriostático y bactericida y los usos de la forma activa de LytM de S. aureus
CN103288968A (zh) 一种抗肿瘤靶向复合物及其制备方法和应用
JPS6112920B2 (cg-RX-API-DMAC10.html)
JP2024510906A (ja) 重症筋無力症の治療的又は予防的処置用のワクチン
JP2548923B2 (ja) リゾチ−ム由来のペプチド
Järver et al. Chemical synthesis and evaluation of a backbone‐cyclized minimized 2‐helix Z‐domain